REG - Spire Healthcare Grp - Director/PDMR Shareholding

Spire HealthcareAnnouncement

Yesterday 11:45

For best results when printing this announcement, please click on link below:
https://newsfile.refinitiv.com/getnewsfile/v1/story?guid=urn:newsml:reuters.com:20250624:nRSX1929Oa&default-theme=true

RNS Number : 1929O  Spire Healthcare Group PLC  24 June 2025

Spire Healthcare Group plc (the "Company")

24 June 2025

 

Notification of Transactions of Persons Discharging Managerial
Responsibilities

Exercise of Sharesave (SAYE) Plan options

The Company announces the following changes to the interests of the Executive
Directors listed below in the Company's ordinary shares of 1 pence each (the
"Shares").

 

On 1 June 2025, the options granted on 26 April 2022 under the Company's
Sharesave Plan (the "2022 Sharesave Plan") reached maturity and became capable
of exercise.

 

The Executive Directors listed below exercised their options and acquired
Shares at the exercise price of £1.98 per Share on 24 June 2025. All Shares
acquired have been retained by the individuals concerned. The exercise price
was set at the point of grant and was determined in accordance with the
valuation methodology agreed with HM Revenue & Customs and the rules of
the 2022 Sharesave Plan.

 

 Executive Directors  Number of Shares acquired  Exercise Price per Share
 Justin Ash           1,818                      £1.98
 Harbant Samra        1,818                      £1.98

 

Following the transactions, Justin Ash holds 1,300,459 Shares and Harbant
Samra holds 55,077 Shares.

 

 

Name of contact and telephone number for queries:

Mantraraj Budhdev

Group General Counsel and Company Secretary

Spire Healthcare Group plc

Tel: 07787 283848

 

 

The information set out below is provided in accordance with the requirements
of the UK Market Abuse Regulation.

 

Notification and public disclosure of transaction by persons discharging
managerial responsibility and persons closely associated with them

 

 1   Details of the person discharging managerial responsibilities/person closely
     associated
 a)  Name                                                         Justin Ash

 2   Reason for the notification
 a)  Position/status                                              Chief Executive Officer

 b)  Initial notification /Amendment                              Initial notification

 3   Details of the issuer, emission allowance market participant, auction
     platform, auctioneer or auction monitor
 a)  Name                                                         Spire Healthcare Group plc

 b)  LEI                                                          213800IBJPW3SE2RA350

 4   Details of the transaction(s): section to be repeated for (i) each type of
     instrument; (ii) each type of transaction; (iii) each date; and (iv) each
     place where transactions have been conducted
 a)  Description of the financial instrument, type of instrument  Ordinary shares of 1 pence each

     Identification code

                                                                  GB00BNLPYF73
 b)  Nature of the transaction                                    Exercise of options under the Company's 2022 Sharesave Plan. All shares have
                                                                  been retained.
 c)  Price(s) and volume(s)                                       Price(s)                                 Volume(s)
     £1.98                                                                                                 1,818

 d)  Aggregated information                                       As above

     - Aggregated volume

     - Price
 e)  Date of the transaction                                      2025-06-24
 f)  Place of the transaction                                     Outside of trading venue

 

 

 1   Details of the person discharging managerial responsibilities/person closely
     associated
 a)  Name                                                         Harbant Samra

 2   Reason for the notification
 a)  Position/status                                              Chief Financial Officer

 b)  Initial notification /Amendment                              Initial notification

 3   Details of the issuer, emission allowance market participant, auction
     platform, auctioneer or auction monitor
 a)  Name                                                         Spire Healthcare Group plc

 b)  LEI                                                          213800IBJPW3SE2RA350

 4   Details of the transaction(s): section to be repeated for (i) each type of
     instrument; (ii) each type of transaction; (iii) each date; and (iv) each
     place where transactions have been conducted
 a)  Description of the financial instrument, type of instrument  Ordinary shares of 1 pence each

     Identification code

                                                                  GB00BNLPYF73
 b)  Nature of the transaction                                    Exercise of options under the Company's 2022 Sharesave Plan. All shares have
                                                                  been retained.
 c)  Price(s) and volume(s)                                       Price(s)                                 Volume(s)
     £1.98                                                                                                 1,818

 d)  Aggregated information                                       As above

     - Aggregated volume

     - Price
 e)  Date of the transaction                                      2025-06-24
 f)  Place of the transaction                                     Outside of trading venue

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact
rns@lseg.com (mailto:rns@lseg.com)
 or visit
www.rns.com (http://www.rns.com/)
.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our
Privacy Policy (https://www.lseg.com/privacy-and-cookie-policy)
.   END  DSHBGGDLCDDDGUS